Start your personalized transformation with a free consult!
Reaching your goal weight while on GLP-1 medications represents a significant milestone in your weight loss journey, but it also marks the beginning of a new phase that many patients find themselves navigating without clear guidance. The … Read more
If you’re looking into prescription weight loss options, two medications keep coming up: tirzepatide and semaglutide. You’ve probably heard they’re both effective GLP-1 medications, and clinical research backs that up when they’re used alongside diet and exercise changes. But here’s the thing: they don’t work exactly the same way, and … Read more
GLP-1 medications have transformed how we approach weight management and metabolic health, but their effects don’t end there. These medications may create changes in your gut microbiome that can be challenging as your body adapts to treatment … Read more
If you’re considering prescription support for weight loss, chances are you’ve come across both Zepbound® and Wegovy®. These once-weekly GLP-1 medications are among the most effective treatments available, but while they are similar, there are important differences … Read more
Semaglutide, the active ingredient in brand names like Ozempic® and Wegovy® has quickly become one of the most widely prescribed medications for weight loss and type 2 diabetes management. Semaglutide has helped many people achieve lasting health … Read more
Planning your 2025 weight loss journey? Depending on your plan, FSA and/or HSA funds may be eligible to use with prescription weight loss medications. If not, you still have flexible ways to manage costs. Whether you’re considering … Read more
In today’s business world, healthy employees are a key driver of company success. As more employers recognize this, the demand for effective corporate wellness programs continues to rise. Ivím Health is leading the charge with its innovative … Read more
For those considering Wegovy® (semaglutide), Ozempic® (semaglutide), or compounded semaglutide for weight loss or as a treatment option for type 2 diabetes management, gaining clarity on the financial implications is important. This overview examines costs with insurance … Read more
FDA notice on Zepbound™/Mounjaro® shortage: On December 19th, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Patients may continue receiving essential copies through … Read more
At Ivím Health, our mission is to deliver unparalleled, personalized care that goes far beyond basic healthcare—and our membership model allows us to do just that. We’re proud to offer so much more than just weight loss … Read more
